GenfitAct. Aktie
| 3,61EUR | 0,57EUR | 18,59% |
WKN DE: A0LGJ2 / ISIN: FR0004163111
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 130 | 122 | 148 | 159 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,01 | 0,66 | 0,14 | 0,18 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 185 | 268 | 158 | 113 | 93 |
| Summe Anlagevermögen | 169 | 193 | 169 | 138 | 131 |
| Summe Aktiva | 198 | 281 | 215 | 173 | 151 |
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 186 | 74 | 75 | 70 | 62 |
| Summe Fremdkapital | 215 | 163 | 121 | 106 | 82 |
| Summe Eigenkapital | -17 | 119 | 94 | 67 | 69 |
| Summe Passiva | 198 | 281 | 215 | 173 | 151 |
Adresse
| Parc Eurasante, 59120 Loos | |
| Telefon | +33 (3) 20-16-40-00 |
| Fax | +33 (3) 20-16-40-01 |
| Internet | http://www.genfit.com |
Management
|
Anne-Hélène Monsellato
Independent Director |
|
Carol L. Addy
Chief Medical Officer |
|
Catherine Larue
Independent Director |
|
Dean W. Hum
Chief Scientific Officer |
|
Eric Baclet
Vice Chairman |
|
Florence Séjourné
Director |
|
Jean-Christophe Marcoux
Chief Corporate Affairs Officer |
|
Jean-François Mouney
Chairman |
|
Jean-François Tiné
Independent Director |
|
John Brozek
Vice President-Data & Information Technology |
|
Katherine Bach Kalin
Independent Director |
|
Laurent Lannoo
Secretary & Director-Legal Affairs |
|
Meriam Kabbaj
Chief Technology Officer |
|
Pascal Caisey
Chief Operating Officer |
|
Pascal Prigent
Chief Executive Officer |
|
Sandra Silvestri
Director |
|
Stefanie Magner
Chief Compliance Officer |
|
Thomas Baetz
Chief Financial Officer |
|
Tom Huijbers
Executive Vice President-Regulatory Affairs |
|
Émilie Desodt
Executive Vice President-Human Resources |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
